In the near future, the CBD, THC or other cannabinoids you consume in edibles or medications may not be derived from cannabis at all, but grown in a laboratory.
Kevin Chen, CEO and co-founder of Hyasynth Bio, describes the Montreal-based start-up as "focused on engineering strains of yeast to produce the active compounds of cannabis without having to grow plants."
Recent comments
1 day 8 hours ago
4 weeks 1 day ago
5 weeks 2 days ago
5 weeks 2 days ago
26 weeks 2 days ago
30 weeks 3 days ago
32 weeks 23 hours ago
32 weeks 1 day ago
44 weeks 3 days ago
50 weeks 1 day ago